Insufficient scRNA-seq data for expression of CHRND at single-cell level.
Insufficient scRNA-seq data for expression of CHRND at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
muscle | 100% | 7354.10 | 803 / 803 | 0% | 0 | 0 / 0 |
brain | 73% | 12.12 | 1921 / 2642 | 3% | 0.05 | 20 / 705 |
adrenal gland | 59% | 6.96 | 152 / 258 | 7% | 0.36 | 16 / 230 |
spleen | 56% | 7.19 | 134 / 241 | 0% | 0 | 0 / 0 |
ovary | 37% | 4.94 | 67 / 180 | 9% | 0.40 | 37 / 430 |
heart | 41% | 4.39 | 349 / 861 | 0% | 0 | 0 / 0 |
pancreas | 33% | 3.32 | 107 / 328 | 0% | 0 | 0 / 178 |
skin | 27% | 5.45 | 489 / 1809 | 5% | 0.20 | 23 / 472 |
stomach | 21% | 1.70 | 75 / 359 | 3% | 0.07 | 8 / 286 |
prostate | 17% | 26.95 | 42 / 245 | 5% | 0.24 | 25 / 502 |
peripheral blood | 18% | 2.22 | 170 / 929 | 0% | 0 | 0 / 0 |
lung | 14% | 1.41 | 81 / 578 | 2% | 0.08 | 27 / 1155 |
liver | 8% | 0.91 | 19 / 226 | 6% | 0.89 | 26 / 406 |
thymus | 13% | 2.13 | 85 / 653 | 2% | 0.04 | 10 / 605 |
breast | 14% | 3.01 | 62 / 459 | 1% | 0.07 | 7 / 1118 |
intestine | 11% | 1.00 | 104 / 966 | 2% | 0.16 | 10 / 527 |
adipose | 12% | 1.98 | 149 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 12% | 6.37 | 163 / 1335 | 0% | 0 | 0 / 0 |
kidney | 10% | 0.81 | 9 / 89 | 2% | 0.04 | 17 / 901 |
uterus | 4% | 0.28 | 7 / 170 | 8% | 9.46 | 35 / 459 |
esophagus | 9% | 3.28 | 124 / 1445 | 1% | 0.02 | 2 / 183 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.98 | 3 / 45 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.37 | 6 / 504 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051899 | Biological process | membrane depolarization |
GO_0003009 | Biological process | skeletal muscle contraction |
GO_0060079 | Biological process | excitatory postsynaptic potential |
GO_0007165 | Biological process | signal transduction |
GO_0034220 | Biological process | monoatomic ion transmembrane transport |
GO_0095500 | Biological process | acetylcholine receptor signaling pathway |
GO_0006936 | Biological process | muscle contraction |
GO_0050905 | Biological process | neuromuscular process |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0006812 | Biological process | monoatomic cation transport |
GO_0048630 | Biological process | skeletal muscle tissue growth |
GO_0050881 | Biological process | musculoskeletal movement |
GO_0007271 | Biological process | synaptic transmission, cholinergic |
GO_0005886 | Cellular component | plasma membrane |
GO_0031594 | Cellular component | neuromuscular junction |
GO_0043005 | Cellular component | neuron projection |
GO_0045202 | Cellular component | synapse |
GO_0099634 | Cellular component | postsynaptic specialization membrane |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0005892 | Cellular component | acetylcholine-gated channel complex |
GO_1904315 | Molecular function | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential |
GO_0015464 | Molecular function | acetylcholine receptor activity |
GO_0042166 | Molecular function | acetylcholine binding |
GO_0022848 | Molecular function | acetylcholine-gated monoatomic cation-selective channel activity |
Gene name | CHRND |
Protein name | Cholinergic receptor nicotinic delta subunit (cDNA FLJ56573, highly similar to Acetylcholine receptor protein subunit delta) Cholinergic receptor nicotinic delta subunit Acetylcholine receptor subunit delta |
Synonyms | ACHRD |
Description | FUNCTION: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. . |
Accessions | C9JJV8 F8WBS0 ENST00000412233.5 B4DKT6 Q07001 F8WB46 ENST00000446616.1 ENST00000543200.5 [Q07001-2] ENST00000258385.8 [Q07001-1] ENST00000441621.6 ENST00000449596.5 |